Integrating network pharmacology and animal experimental validation to investigate the mechanism of lotus leaf in obesity

This publication has 27 references indexed in Scilit:

• A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
  Metabolism, 2022
• Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases
  Pharmacological Research, 2022
• Pu-erh tea ameliorates obesity and modulates gut microbiota in high fat diet fed mice
  Food Research International, 2021
• Comparison of main chemical composition of Plantago asiatica L. and P. depressa Willd. seed extracts and their anti-obesity effects in high-fat diet-induced obese mice
  Phytomedicine, 2021
• Regulation and Functions of the Renin‐Angiotensin System in White and Brown Adipose Tissue
  2017
• Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?
  Current Cardiology Reports, 2012
• Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics
  International Journal of Obesity, 2011
• Future Therapeutic Directions in Reverse Cholesterol Transport
  Current Atherosclerosis Reports, 2010
• The enduring effects of abuse and related adverse experiences in childhood
  European Archives of Psychiatry and Clinical Neuroscience, 2005
• Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia
  The American Journal of Cardiology, 2005